Abingdon, United Kingdom

Christopher John Brown

USPTO Granted Patents = 24 

 

 

Average Co-Inventor Count = 8.4

ph-index = 5

Forward Citations = 67(Granted Patents)


Location History:

  • Oxfordshire, GB (2016)
  • Abingdon, GB (2014 - 2024)

Company Filing History:


Years Active: 2014-2025

where 'Filed Patents' based on already Granted Patents

24 patents (USPTO):

Title: Christopher John Brown: Innovator in Imaging Probes for Huntington’s Disease

Introduction: Christopher John Brown, based in Abingdon, GB, has made significant contributions to the field of biomedicine with an impressive portfolio of 21 patents. His work primarily focuses on the development of imaging agents designed to detect and monitor conditions associated with the huntingtin protein, crucial in the study of Huntington’s disease.

Latest Patents: Among his latest patents, Brown has introduced innovative probes for imaging the huntingtin protein. One notable patent involves imaging agents that comprise a specific compound and its pharmaceutically acceptable salt, along with methods for their application. Another of his significant contributions includes compounds and probes that are useful for detecting conditions or disorders related to protein aggregation, highlighting his commitment to advancing medical diagnostics.

Career Highlights: Brown has held key positions in prestigious organizations where he has honed his expertise. He has contributed to CHDI Foundation, Inc., a nonprofit organization dedicated to developing therapies for Huntington’s disease. Additionally, he has worked with Respivert Limited, a company focusing on respiratory diseases, further diversifying his experience in biomedical innovation.

Collaborations: Throughout his career, Brown has collaborated with notable professionals including Celia Dominguez and Michael Edward Prime. His partnerships have fostered innovative research, culminating in groundbreaking patents and advancements in the understanding of protein-related disorders.

Conclusion: Christopher John Brown's relentless pursuit of innovation in the realm of biomedical research has led to significant advancements in the imaging of the huntingtin protein. His work not only pushes the boundaries of science but also offers hope for better diagnosis and treatment options for patients afflicted by Huntington's disease. With a remarkable portfolio and strong collaborative efforts, Brown continues to be a pivotal figure in the field of medical imaging.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…